Abstract B039: A Phase 1/2 Study of Dendrimer-Enhanced (DEP) SN38 (SN38-SPL9111/DEP Irinotecan) in Patients with Advanced Solid Tumours
Molecular Cancer Therapeutics(2023)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined